Paraxazone

This classification denotes an anxiolytic with the molecular formula C10H10N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2H6ON8WA7L, chemically known as 2,3-dihydro-3-oxo-4h-1,4-benzoxazine-4-acetamide. but generally known as paraxazone, which bears US NIH Compound Identifier 3047812. European Medicines Agency schedules Paraxazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09619MIG. The term PARAXAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). PARAXAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule paraxazone under HS 29349990 and SITC 51579. As of Q4 2014, PARAXAZONE remains the US FDA Preferred Term for this commodity. Paraxazone bears US NLM identifiers UMLS ID C1882286 and NCI Concept Code C66314. SMILES: C1C(=O)N(C2=CC=CC=C2O1)CC(=O)N.